Covered recipient · General Payments record
LAURA M LUEBKE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,986.97
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $771.15 | 33 |
| Education | $19.25 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $242.61 | 13 |
| ABBVIE INC. | $227.83 | 6 |
| UCB, Inc. | $58.10 | 3 |
| PFIZER INC. | $53.55 | 2 |
| Alexion Pharmaceuticals, Inc. | $46.76 | 2 |
| GlaxoSmithKline, LLC. | $24.18 | 1 |
| GENZYME CORPORATION | $23.34 | 1 |
| Acerta Pharma LLC | $22.36 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.36 | 1 |
| SOBI, INC | $19.25 | 1 |
| Genentech USA, Inc. | $19.01 | 1 |
| ANI Pharmaceuticals, Inc. | $16.48 | 1 |
| Kiniksa Pharmaceuticals International, plc | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563974 | CMS |
| ABBVIE INC. | $6.67 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563976 | CMS |
| ABBVIE INC. | $21.36 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563978 | CMS |
| ABBVIE INC. | $23.46 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563980 | CMS |
| ABBVIE INC. | $28.53 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563982 | CMS |
| ABBVIE INC. | $128.33 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563984 | CMS |
| Alexion Pharmaceuticals, Inc. | $23.18 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094031973 | CMS |
| Alexion Pharmaceuticals, Inc. | $23.58 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094035490 | CMS |
| Amgen Inc. | $4.25 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314844 | CMS |
| Amgen Inc. | $28.82 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314832 | CMS |
| Amgen Inc. | $21.16 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314840 | CMS |
| Amgen Inc. | $5.55 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117615003 | CMS |
| Amgen Inc. | $20.11 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117615005 | CMS |
| Amgen Inc. | $26.25 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314834 | CMS |
| Amgen Inc. | $4.10 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314846 | CMS |
| Amgen Inc. | $27.63 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314836 | CMS |
| Amgen Inc. | $30.98 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314838 | CMS |
| Amgen Inc. | $26.79 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314848 | CMS |
| Amgen Inc. | $7.58 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314850 | CMS |
| Amgen Inc. | $23.92 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117615007 | CMS |
| Amgen Inc. | $15.47 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117314842 | CMS |
| ANI Pharmaceuticals, Inc. | $16.48 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091167622 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.36 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105862428 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.36 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118104113 | CMS |
| Genentech USA, Inc. | $19.01 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133169749 | CMS |
| GENZYME CORPORATION | $23.34 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139762866 | CMS |
| GlaxoSmithKline, LLC. | $24.18 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116019212 | CMS |
| Kiniksa Pharmaceuticals International, plc | $15.57 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154892325 | CMS |
| PFIZER INC. | $23.60 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131792441 | CMS |
| PFIZER INC. | $29.95 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131401446 | CMS |
| SOBI, INC | $19.25 | 09/04/2024 | Education | Undisputed | 01/23/2026 | 1141411154 | CMS |
| UCB, Inc. | $19.66 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143176362 | CMS |
| UCB, Inc. | $20.94 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143176364 | CMS |
| UCB, Inc. | $17.50 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143176366 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.